| Product NDC: | 45802-263 |
| Proprietary Name: | Clindamycin Phosphate |
| Non Proprietary Name: | Clindamycin Phosphate |
| Active Ingredient(s): | 10 mg/mL & nbsp; Clindamycin Phosphate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 45802-263 |
| Labeler Name: | Perrigo New York Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065049 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060531 |
| Package NDC: | 45802-263-93 |
| Package Description: | 69 APPLICATOR in 1 JAR (45802-263-93) > 1 mL in 1 APPLICATOR |
| NDC Code | 45802-263-93 |
| Proprietary Name | Clindamycin Phosphate |
| Package Description | 69 APPLICATOR in 1 JAR (45802-263-93) > 1 mL in 1 APPLICATOR |
| Product NDC | 45802-263 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clindamycin Phosphate |
| Dosage Form Name | SOLUTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20060531 |
| Marketing Category Name | ANDA |
| Labeler Name | Perrigo New York Inc |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |